1093.HK CSPC PHARMA | HK1093012172
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 35.132.261.140 | 35.573.924.320 | 1.24% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 0,71 | 0,69 | 3.89% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 6 | 7 | 14.29% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |